SCHEDULE 13G--ADEONA/STERGIS

Company

Theriva Biologics, Inc.

Filed

February 12, 2010

Accession Number

0000890163-10-000025

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →